Versant Ventures related stories
All articles and analysis
An eye toward venture: The busiest LPs of 2020Amid lockdowns and remote working challenges, here are the top 10 investors who committed to venture funds in 2020.
LP roundup: US pensions pump nearly a quarter billion dollars into fundsLPs announced $225m of new venture commitments including multiple organizations that haven't invested in the asset class in years.
VC going to Canadian tech companies drops in Q3: CVCAVenture capital investment in Canadian technology companies declined in the third quarter of 2020, according to a report by the Canadian Venture Capital and Private Equity Association.
LP roundup: Illinois Municipal Retirement Fund invests in four VC vehiclesThe pension system announced $85m of re-up commitments; MassPRIM made a re-up of its own into TCV's latest late- and growth-stage-focused fund.
IMRF confirms $85m in commitmentsThe US public pension has backed four venture capital funds in its latest round of commitments.
VC-backed Aligos Therapeutics goes publicAligos Therapeutics, a biopharmaceutical company focused on treating viral infections and liver diseases, has raised about $150 million for its IPO after pricing its 10 million shares at $15 per share.
RayzeBio scores $45m Series ASan Diego-based RayzeBio Inc, a biotech company, has raised $45 million in Series A financing.
- VectivBio reels in $110m
VectivBio AG, a Swiss developer of transformational medicines for patients with serious rare diseases, has raised $110 million in financing.
- Epidarex sells Enterprise Therapeutics' lead program
Roche is acquiring Enterprise Therapeutics' lead program from Epidarex Capital.
- Graphite Bio snags $45m Series A
Graphite Bio, a next-generation gene editing company, has secured $45 million in Series A financing.